NCT07221331 2026-04-16
PRECIOUS Egypt
AstraZeneca
Recruiting
Clinical Trials
7 trialsNCT00111384 2026-04-15
Study of Disease Severity in Adults With Neurofibromatosis Type 1 (NF1)
National Institutes of Health Clinical Center (CC)
Completed
NCT00314119 2026-04-14
Natural History and Biology of Skin Neurofibromas in Neurofibromatosis Type 1
National Institutes of Health Clinical Center (CC)
Completed
NCT06880991 2026-04-09
Development of Patient-Reported Outcome Measures Assessing Tumor Visibility and Appearance Concerns in Neurofibromatosis Type 1: A Qualitative Study
National Institutes of Health Clinical Center (CC)
Recruiting
NCT02544022 2026-04-07
Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)
National Institutes of Health Clinical Center (CC)
Recruiting
NCT06360406 2026-03-31
Real-World Treatment Study of Koselugo (Selumetinib)
AstraZeneca
Recruiting
NCT00924196 2026-03-20
Natural History Study of Patients With Neurofibromatosis Type I
National Institutes of Health Clinical Center (CC)
Active not recruiting